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Abstract
Background: The interest and activity in measuring and reporting the impact of publicly funded health and medical
research has grown rapidly in recent years. Research evaluation typically relies on researchers for much of the
information for an impact assessment. However, the acceptability and feasibility of this activity among health
researchers is unknown. The aim of this study was to understand the role and opinions of cancer researchers
in the growing area of impact evaluation activity, to inform the logistics of a sustainable program of impact
evaluation.
Methods: A brief anonymous online survey was administered to 95 current and past grant recipients funded
through the external grants program at Cancer Council New South Wales. Eleven survey statements were
constructed with Likert responses and supplemented with two open-ended questions. The statements covered the
conceptual, attitudinal and practical aspects of impact evaluation. The survey targeted researchers from the
full spectrum of cancer control research classifications. Descriptive analyses obtained response frequencies and
percentages.
Results: Forty-five cancer researchers completed the survey (response rate 47%) and 77% were Associate
Professors or Professors. Responses were polarised for questions relating to engaging with research end-users,
perceived time-pressure to collate data, and pressure to produce research outputs. Some researchers emphasised that
quality was an important goal over quantity and warned that collecting impact data created incentives and
disincentives for researchers.
Conclusion: There was mixed support and acceptance among senior cancer researchers in Australia on their
perceived role and engagement with research impact activities. Sole reliance on researchers for collating and
reporting impact data may be problematic. Requesting information from researchers could be minimised and
confined to final reports and possible verification of externally-led evaluations.
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Background
In recent years there has been significant interest in
measuring and reporting the impact of publicly funded
health and medical research. This has occurred as
funding agencies face increased pressure to demon-
strate accountability and for informing future grant
decisions [1]. Funding agencies also use impact
assessments for advocacy purposes, clearly articulating
research to the general population, and for internal
analysis, to identify research strategies that are most
likely to produce future benefit.
Capturing the outputs for individual research projects
or a cohort of projects typically relies on principal
researchers for much of the information. An impact
assessment will usually include information not only for
publications and academic research outputs but on less
visible outputs such as building workforce capacity,
supervision of PhD and masters students, patent
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applications, leveraged funds, evidence of health policy
changes, wider clinical practice changes and so forth.
The participation by the researcher is crucial and the
researcher is essentially the central portal for this in-
formation [1]. Data on publications and research out-
puts are routinely collected through annual reporting
processes which researchers are familiar and have
high compliance with (sometimes mandated by the
funder) [2]. Downstream impact data is less routinely
collected and researchers are not as used to reporting
this data. This data can be collected by surveys tar-
geted at groups of researchers within an organisation
over a set time period [3].
Although the principal researcher (grant recipient) of-
fers a prime source of data on research outputs, difficulties
in implementation of an impact assessment may mean
they are not the obvious starting point for collection of
impact data. Primarily the assessment is an administrative
function and the burden to researchers for yet more non-
research activity within their routine jobs is mounting [4].
The opportunity cost of spending time on this activity is
the foregone activities of teaching, laboratory work or
other core research priorities. Studies and reports on
health and medical research impact assessment show that
questionnaire methods asking researchers to provide
output information (i.e. bibliometrics, academic outputs
and policy impacts) have poor response rates [2, 3, 5].
Researchers may also provide incomplete data or, if tied to
funding, they may be inclined to exaggerate their claims
on impact and introduce a biased viewpoint. Conversely,
other studies have shown from triangulation of data
sources, that surveys of the lead investigators underesti-
mate their impacts [3]. Researchers do not always com-
municate their outputs clearly and they may also be
unaware of downstream events.
Ideally, organisations interested in research impact
evaluation need to have engaged researchers and commu-
nity members. In a recent Australian report, one of the
conclusions was that “there is a need, and an opportunity,
to create and embed a culture of and expectation for
impact within Australian universities and wider society”
[6]. However, beyond the small number of outspoken
researchers who have submitted their opinions in various
forums [4, 7, 8], there is a lack of understanding on what
the broader research community attitudes and values
towards research impact are. We undertook a brief survey
aimed at principal cancer researchers across Australia
who were funded through the external grants program at
the Cancer Council New South Wales (CCNSW) in order
to understand their role and sentiments in this growing
area of impact work.
Understanding the views of cancer researchers is
important as cancer is a leading cause of morbidity
and mortality worldwide, and attracts significant research
investment of research teams around the globe. In
Australia alone, more than $1 billion was provided be-
tween 2006 and 2011 by all major cancer research funders
to support cancer research and programs [9]. CCNSW is
the largest non-government funder of cancer research in
the state of New South Wales as well as Australia more
broadly. Since 2006, CCNSW has committed close to
$100 million in new funding through the external research
program to researchers across Australia. Understanding
the views of cancer researchers on evaluating the im-
pact of their research allows us to better inform the
development and implementation of the evaluation and
monitoring framework used to measure research im-
pact of CCNSW research funding.
Methods
Survey sample
With the assistance of the CCNSW Research Strategy
Unit, the survey targeted current and past grant re-
cipients identified by CCNSW records (n = 95). These
included the principal researchers who had been or
were involved in projects covering a range of competitive
grant schemes administered by the CCNSW and strategic
research partnership, program, project and innovator
grants. It also covered the full spectrum of cancer
control research as categorised using the Common
Scientific Outcomes from biology through to scientific
model systems.
Survey content
The online survey was developed using the Qualtrics
platform. The survey questions were developed by the
authors and tested among colleagues with final approval
from the CCNSW Research Strategy Unit. The content
and wording of the survey questions were intended to
be somewhat provocative so that respondents would
avoid neutral or indifferent responses (Box 1). The survey
covered both the conceptual (Questions 1–4), practical
(Questions 5–7) and attitudinal (Questions 8–10) issues
of research impact evaluation. The statements were devel-
oped by the authors and derived through reading of pub-
lished papers and commentaries [2–5, 7, 8, 10] and
reports [1, 6, 11, 12] on this topic. A short survey with
closed and open-ended questions was considered the most
appropriate method to obtain both the quantitative data
regarding researchers’ attitudes and views, as well as
qualitative data allowing further exploration of issues,
taking into consideration the issue of time-poor senior
researchers.
In total, 11 statements were provided with responses
using a Likert scale; ‘strongly agree’, ‘agree’, ‘neither
agree or disagree’, ‘disagree’, and ‘strongly disagree’
(Box 1). Question 5 was open-ended and specifically
asked what impact measures should be used as most
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relevant for the cancer researcher’s work. The final ques-
tion was open-ended and intended to elicit other respond-
ent concerns or comments that were not already covered.
The survey was planned to take no more than 5 minutes
but with the addition of the final open question, may have
taken longer depending on respondent input. There was
no word limit for the open-ended questions. Two add-
itional questions, the type of cancer research (i.e. biology,
aetiology, treatment, prevention, cancer control/survivor-
ship/outcomes, scientific model systems) and researcher
career level (i.e. professor, associate professor, post-doctoral
researcher for at least five years or less than five years),
were asked in order to understand how these attributes
influenced the responses.
Recruitment and data collection
The principal investigators were emailed an invi-
tation to complete the survey via a hyperlink. To
maximise response rates, the survey responses were
anonymous and no identifying information was col-
lected that could be traced back to the individual
cancer researcher. Ethics approval for the survey was
received by the Griffith University Human Research
Ethics Committee.
The survey was open and accessible to respondents
from 11th June to 4th July 2014 (3½weeks). Two re-
minder emails were sent during this time to prompt
further completions. After a total of three emails, no
further responses were received and the survey was
closed. Descriptive analyses were performed to obtain the
counts and percentages of responses. Cross-tabulations
and χ2 tests were planned for subgroup analyses by
researcher career level and type of research.
Results
In total, 45 out of 95 cancer researchers completed
the survey (response rate 47%). Most respondents
were professors 19 (44%) or associate professors 14
(33%), and the most common types of research were
biology 16 (37%) and treatment 14 (33%) (Table 1).
The results of the closed questions are presented in
Figure 1.
Overall, there was clear consensus among respondents
for some questions but substantial variability for others.
Respondents had a keen sense of social responsibility to
deliver meaningful outcomes from their research activ-
ities (Question 1, 35/45 or 78% strongly agreed). There
were different views about their role in being account-
able to end-users of the research (Fig. 1, Question 2).
Although the question did not define end-users or
stakeholders specifically, many disagreed this was a
researcher’s role. This raises the issue that some re-
searchers do not expect or feel the need to communicate
their scientific work with the broader community.
Whether this task is seen as difficult, too time con-
suming, or whether there are communication chal-
lenges, is unknown.
Respondents generally agreed that a broad range of
impact indicators were needed and were important
beyond bibliometrics and traditional academic outputs
only (Fig. 1, Question 3). However, these were still
regarded as the best short-term measures when bio-
logical or discovery science is a long-term venture.
There was a sense that publication bibliometrics did
not explain the whole story but at least were object-
ive and quantitative tools. Most agreed or strongly
agreed that broader downstream indicators of impact
were important (Fig. 1, Question 4) but could be
difficult to demonstrate and were not in the control
of the researcher.
Selected free-text comments from cancer researchers
are shown below.
Box 1 Survey questions
Q1. I am conscious that, because I am paid with public/charitable
funds, I need to deliver meaningful outcomes from my research.
Q2. I should be accountable for the specified outputs of my research
project/program but not for engaging with stakeholders or the
end-users of the research.
Q3. Research impact should only be based on measurable academic
outputs, e.g. reports, publications, h index, citations, conference
presentations, etc. (subject to their limitations).
Q4. Measures of research impact should include the broader
downstream influences on patients, improved health and
well-being, healthcare delivery and improving society (subject to
their limitations).
Q5. For your type of research, what is/are the most appropriate
measure(s) of research impact? (open-ended)
Q6. I would like to have input into what is perceived as the impact
of my research project or program and I accept that it is a
necessary part of my role as a researcher.
Q7. I spend far too much of my time collating evidence on the impact
of my research at the expense of core research or teaching.
Q8. I accept that it is part of my job as a grant reviewer to judge
the potential significance of potential impact of a research
proposal to assist the decision making process.
Q9. I feel a lot of pressure to produce research outputs to the point
that it is hampering my scientific freedom.
Q10. Evaluating the outcomes of my research undermines my
authority and autonomy at undertaking good science.
Q11. The type of health or medical research that best describes
my work is: biology, aetiology, prevention, treatment, cancer
control/survivorship/outcomes, scientific model systems.
Q12. I am at the following level of my career: PhD student,
post-doctoral researcher for less than 5 years, post-doctoral
researcher for more than 5 years, associate professor, professor.
Q13. Additional comments (open-ended).
Responses to all questions except open-ended Questions 5 and 13 used a
Likert scale; ‘strongly agree’, ‘agree’, ‘neither agree or disagree’, ‘disagree’,
and ‘strongly disagree’
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“Basic research will be where the major advances
will come from for the diagnosis and treatment of
cancer in the coming years. The ‘success’ of
individual basic research projects when thinking
only of impacting healthcare in the relatively short
term is very hard to ascertain. It is the body of
literature that basic research contributes to that
provides the invaluable information that will be
Table 1 Number of respondents by their career level and type of cancer research by Common Scientific Outcomes
Post-doc <5 years Post-doc 5+ years Associate Professor Professor Total
Biology 0 (0%) 5 (63%) 6 (43%) 5 (26%) 16 (37%)
Aetiology 1 (50%) 0 (0%) 0 (0%) 1 (5%) 2 (5%)
Prevention 0 (0%) 0 (0%) 2 (14%) 2 (11%) 4 (9%)
Treatment 1 (50%) 2 (25%) 3 (21%) 8 (42%) 14 (33%)
Cancer control, survivorship, outcomes 0 (0%) 0 (0%) 2 (14%) 3 (16%) 5 (12%)
Scientific model systems 0 (0%) 1 (13%) 1 (7%) 0 (0%) 2 (5%)
Total 2 (5%) 8 (19%) 14 (33%) 19 (44%) 43a (100%)
aTwo respondents did not answer the questions of researcher level and type of research.
Fig. 1 Results of survey.
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used to improve the outcomes for cancer patients.
This takes longer than the period of a single grant,
yet the funding of that single grant can have far
reaching (global!) impact.”
“No system works. Comparison between disciplines are
impossible.”
“While some types of research can be measured by the
impact on patients, improved health and well-being,
healthcare delivery and improving society, this does
not apply to all types of research. An appropriate mix
of academic and direct health outcomes are needed
depending on the type of research that is undertaken.”
“The problem in Australia is that the most senior
scientists are not participating in NHMRC [National
Health and Medical Research Council] panels. They
are acting as academy assigners when they should be
reviewing on Panels. Researchers must show what it is
that they have achieved. Relying on metrics such as
number without a measure of quality like the impact
factor, allows those that confuse activity with progress
to prosper at the expense of those who push back the
boundaries of ignorance. See recent PNAS paper from
Harold Varmus http://www.pnas.org/content/111/16/
5773 full on the current problems with our research
system-note the discussion of the damage the current
emphasis on translational research is causing to
discovery. This is a direct product of consumer
involvement and needs to be recognised.”
“The long lead time between discovering new ways
to influence tumour progression, and their (possible)
translation into new treatments, means that impact
on patients is an impractical way to assess research
impact. Discovery science is an incremental process
and basic research can make a real contribution to
future discoveries even though that contribution
may be difficult to quantify. The difficulty in
quantifying eventual impact should not be used as
a reason to minimise support for discovery
research.”
“Translational outcomes that are not reflected in
publications should be highly valued.”
“Measurement of research impact needs to include
a wide variety of assessments that include
traditional publication and presentation assessments
but also peer opinions, end user assessments and
patterns of consistency across research areas that
indicate long term development of sound strategies
rather than scientific opportunism.”
“Observation and measurement usually influence the
phenomenon that is being observed and measured.
Researchers know this all too well. The people who
survey researchers also need to know it. They have a
responsibility to understand the incentives and
disincentives they create. Good research is built on
complex social systems of trust and co-operation as
well as competition, and I am seeing many of the
co-operative/trust systems undermined by the neurotic
pursuit of quantifiable outcomes. ‘Not everything that
counts can be counted, and not everything that can be
counted counts.’ Above all, to count is to intervene. So
intervene carefully.”
“Significance is a flexible issue depending upon who is
assessing, very hard if too much weight is on consumer
evaluation.”
“Quality better than quantity. Lots of cancer research
in Australia, few do it at outstanding and
internationally acclaimed levels and too few
opportunities to translate research findings into
meaningful clinical outcomes. Limited home grown
biotech/pharmaceutical industry, limited venture
capital. Limited options for start-up and spin offs.”
Question 5 was open-ended and requested the re-
searcher to nominate the most suitable outcome measure
pertaining to their research field. Research publications
and academic outputs dominated the responses and
changes in clinical practice was mentioned in 10/14
responses by researchers involved in cancer treatment.
Teaching and mentoring was viewed as important im-
pact indicators while others, reduction in burden of
disease, and patient days in hospital were infrequently
nominated. Responses were elaborated on in many
cases and two examples are:
“Definitely academic (outputs) as noted above
(including student completions) as it is basic
research that provides a knowledge base that
underpins healthcare (drug development, new
diagnostic tests, etc.) but in and of itself will not
‘improve society’, ‘healthcare delivery’, etc. in the
short term.”
“Research publications are crucial but they are not
the full story. My research can and has had an
impact through professional education and changes
to policy (e.g. concerning the use of diagnostic tests).
Research projects are also a means of training
junior researchers, so these are also important (they
are much more accessible these days), as are
conference posters and presentations. A singular
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focus on peer reviewed publications can create
perverse disincentives. Research has an important
role to play in teaching and mentoring junior
colleagues, and its influence is extended through
these activities. ‘Not everything that counts can be
counted’.”
Having input into what is perceived to be the impact
of their research was important to the respondents and
engaging in this activity was acceptable. There were
mixed responses to the question on the time spent
collating information for demonstrating the impact
of their research, with 40% (18/45) indicating that
they spent too much time and 33% (15/45) indicat-
ing that they did not spend too much time on this
task (Fig. 1, Question 7). This is likely to reflect the
willingness of researchers to complete requests to
provide impact indicators and shows the mix of ex-
pectations and work roles. Very senior level re-
searchers may be time poor or engaged in teaching
or clinical roles and the extra burden of this task
perceived as too onerous. However, many appeared
to be resigned to the idea that research impact activ-
ities were part of the job.
There were affirmative responses to their active role in
grant reviewing and using judgement about the signifi-
cance of a research funding proposal (42/45, 93%). The
respondents may be well experienced in this area and
view their qualifications as well-placed to perform this
role, although one professor in the free text comments
contradictedthisbysayingtherewerenotenoughscientists
onreviewpanels inAustralia.
Mixed responses were received on the question
of wthe perceived pressure to produce traditional
academic outputs (i.e. publications, conference pre-
sentations, etc.; Fig. 1, Question 9). Some respon-
dents confirmed they were under pressure while
others emphasized the priority towards quality versus
quantity of their outputs. However, in the follow-up
question on autonomy of producing good science,
many indicated they disagreed (27/45, 60%) that
striving for research outcomes undermined their
authority or autonomy in scientific research. This
may show that the researchers were largely secure in
their work environment and the research outputs
they produced. Again, this may be influenced by the
seniority of the respondents answering this survey.
Further comments from the open-ended answers, as
indicated above, where all researchers completed this
question, showed that the researchers:
 Believed that the purpose of impact activity should
not be used for future funding decisions;
 Acknowledged the difficulties and pressures to produce
good outputs but interference from stakeholders with
the research process was unwelcome;
 Understood that the type of research will dictate the
type of outcomes possible or those reasonable to
quantify;
 Believed that quality of outputs or publications was
a more important goal than quantity;
 Felt that there were few opportunities for advancing
biological discoveries into clinical outcomes in
Australia; and
 Felt that collecting research impact data was
intervening in research because it created incentives
and disincentives for researchers to engage in
certain research activities and not others.
Discussion
While there is increasing literature around impact evalu-
ation, as well as the different models and challenges of
such [1, 11–13], the results of this survey contribute to
the under-investigated area of understanding researcher
views about their role in impact evaluation. Recent work
exploring researcher’s views of impact evaluation found
that the term ‘impact’ has different meanings for re-
searchers from different fields (humanities versus basic
science) and researchers across fields have different
motivations for conducting research (e.g. contribute to the
social good, influence policy and practice, or advance car-
eer) [14]. The results of this survey extend this work by
gaining a contemporary understanding of Australian can-
cer researcher’s views on their role in impact evaluation. It
also has practical implications as these results may shape
the way that funding agencies effectively engage with re-
searchers in measuring impact. Understanding the views
of cancer researchers in terms of the role they believe they
should play in impact evaluation is an important element
of a successful research impact evaluation framework.
CCNSW funds cancer researchers across a broad
range of disciplines from basic science through to
applied sciences and intervention projects. Due to the
small sample size, sub-group analysis by type of research
or career level did not produce meaningful outcomes. It
was expected that we would find differences between
career levels, with early career researchers more open to
research impact evaluation and more accepting of this as
their responsibility. Additionally, we were expecting to
see differences between the types of research; in particu-
lar, it was expected that basic science researchers would
have different views on impact evaluation and its
relevance to their field compared to more applied
researchers. This is a potential area for further investiga-
tion with a larger study population.
This survey has confirmed some of the conceptual
challenges of research impact assessment, including
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attributing downstream outputs to a specific grant
source when there is a time lag between funding and
outputs and the choice of impact indicators when
variation in the types of research undertaken occurs
but where comparisons may be required. It is appar-
ent from this study that a balance is required to
source research impact indicators from researchers
while also minimising the additional burden and per-
ceived ‘interference’ with their research. As research
impact assessment is now a fundamental activity for
funding agencies and universities, there is a role for
funding agencies to play in moving towards impact
reporting and evaluation becoming standard practice
while not increasing the burden for researchers too
greatly. This debate around who ultimately should be
responsible for tracking impact (researchers or fun-
ders) is a major challenge of research impact evalu-
ation. Understanding researchers’ views on this issue
helps to inform the development of a framework that
will be acceptable to both researchers and funding
agencies. While it is imperative to obtain researchers’
perspectives on and understanding of their impacts, it
could be argued that there is an inherent conflict of
interest perceived in a system in which those subject
to evaluation are also the sole source of information.
A research evaluation framework which distributes re-
sponsibility to both the researcher and funding agency
may be the most ideal option. Incorporating existing
processes like annual reporting, the onus of data col-
lation could be, in the first instance, on funders ra-
ther than researchers. Principal researchers could
have a more reduced role in impact assessment activ-
ities than previously planned (i.e. a supportive or val-
idating role), and that the key assessment be
performed externally by a dedicated evaluator with
the skills and ability to complete the data synthesis
and interpretation required. Additionally, as re-
searchers are not always aware of their impact, there
may be added value in feeding evaluation results back
to researchers in this way.
It is not only funding agencies that require impact
information but also research organisations such as uni-
versities. While some of the information may already be
centralised or readily accessible (e.g. publication and pa-
tent databases), there are several systems, such as
ResearchFish®, ORCID (Open Researcher and Contribu-
tor ID), and VV-Impact Tracker, which are available to
assist researchers to report the outputs and impact of
their research. With online systems such as Research-
Fish® researchers are required to enter their data, and
therefore the administrative reporting burden is on the
researcher. The benefit of such a system would be if all
or a majority of funding agencies sign up to an online
system thereby reducing the burden on researchers to
some extent, allowing researchers to report the same
information across a number of funders, recording
outputs once, and attributing these to multiple grants
and/or funders. This would allow funders to gather in-
formation from researchers as the grant is ongoing,
and for several years afterwards, building up a data-
base of information that they can analyse to under-
stand the progress, productivity and quality of their
research portfolios. However, online systems such as
ResearchFish® require significant financial investment
from funding agencies over the long-term because re-
search impact on policy and practice can often take
decades in some cases. Importantly, the funding
agency wishing to review this information still needs
to invest resources in expertise to synthesise and in-
terpret the reports provided from online tracking sys-
tems. It is also unclear how compliant researchers will be
in reporting outputs and outcomes after the grant period
has finished, when the report incentive (continual fund-
ing) has ceased.
A clear limitation of this survey was that it was small
and the response rate was below 50%. Therefore, these
findings should be viewed cautiously and may not be
generalizable to the wider cancer research community.
As completion of the survey was anonymous, the extent
and influence of potential selection bias in the survey is
unknown. Respondents may have been knowledgeable,
interested or already engaged in this research impact
work. Senior researchers are often on funding panels
and therefore likely to have an informed understanding
of why funders need to rely on researchers to provide
this information. These researchers also provide an
important link to stakeholders as they act as a conduit
between the funders and the research community. To
our knowledge, this is the first survey to assess the senti-
ments and practicalities of engaging in impact activities
among researchers. Some questions may need improve-
ments in their framing or tone and additional questions
may be worthwhile, such as the researcher’s willingness
to use an online system like ResearchFish® or the re-
searcher’s time spent on communicating the importance
of research impact among junior team members.
Given that the results of this survey support previ-
ous research, in that the term ‘impact’ had different
meanings for researchers across the cancer research
continuum, it may be advisable that cancer funding
bodies communicate their expectations early, at the
grant acceptance stage, about the extent and types of
data they expect grant recipients to collate. Expecta-
tions for basic science cancer researchers could be
quite different from those of more applied cancer re-
searchers, where funding agencies would require more
traditional outputs for basic science researchers com-
pared to broader impact expectations for clinical or
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public health researchers. It may also be advisable
that funders engage with grant recipients to not only
state their expectations but to communicate specific-
ally why impact information is required and the value
it has for the funder as a means of influencing re-
searcher and donor behaviours and communications
around such reporting policies.
Conclusions
There is mixed support and acceptance among senior
cancer researchers in Australia on their perceived role
and engagement with research impact activities. Re-
search impact evaluation needs to be a collaborative
approach between researchers and funding organisa-
tions. Sole reliance on researchers for key information
on research outputs is problematic. Requesting informa-
tion from researchers could be minimalized and confined
to the existing final reports and possible verification of
completed evaluations.
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